Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Masimo Corp (NASDAQ:MASI)

Delayed Data
As of 2:45pm ET
 +0.34 / +0.87%
Today’s Change
Today|||52-Week Range
WaferGen Launches ICell8 Single-Cell System, Shares Fall
2:50pm / Zacks.com
PRA Health, AMR Team Up to Advance Vaccine Studies
Sep 30 / Zacks.com
Luminex (LMNX) Shares Rally on FDA Approval for ARIES
2:02pm / Zacks.com
Veeva's Zinc Ahead Deal: Focus on Compliance Management
Sep 30 / Zacks.com
Varian (VAR) Receives FDA Clearance, CE Mark for VitalBeam
1:28pm / Zacks.com
Intersect ENT Rallies on FDA Submission for PROPEL Mini
Sep 30 / Zacks.com
Inogen (INGN) Crumbles: Stock Falls by 5%
9:40am / Zacks.com
Veeva Systems Brings In-Built Reporting for Business Users
Sep 29 / Zacks.com
Varian to Add New Tool to Eclipse Treatment Planning System
Oct 07 / Zacks.com
Alere Continues Fight Against HIV, Extends Support to OAFLA
Sep 29 / Zacks.com
IDEXX's Strong CAG Impresses, Stiff Competition Concerns
Oct 06 / Zacks.com
Thoratec's HeartMate III CE Mark Trial Results Positive
Sep 28 / Zacks.com
MedAssets: A Strong Buy on Extended Ties & Solid Q2 Results
Oct 06 / Zacks.com
Thermo Fisher on Track with Life Technologies Synergy
Sep 25 / Zacks.com
Accuray Extends Ties with RaySearch Laboratories, Stock Up
Oct 06 / Zacks.com
Becton, Dickinson: Enteric Parasite Panel Gets FDA Approval
Sep 25 / Zacks.com
St. Jude Faces FDA Warning for Quality Issues at Atlanta Plant
Oct 05 / Zacks.com
athenahealth's Population Health Service Selected by SMG
Sep 25 / Zacks.com
Cardinal Health Buys Cordis, Fortifies Cardiovascular Hold
Oct 05 / Zacks.com
BioMerieux Joins the Ebola Bandwagon: Cepheid in Trouble?
Sep 25 / Zacks.com
C.R. Bard Gains Full Ownership of Medicon, Expands in Japan
Oct 02 / Zacks.com
St. Jude, Mended Little Hearts to Bring Guidebook for CHD
Sep 24 / Zacks.com
Pacific Biosciences Unveils Sequel System, Boosts Portfolio
Oct 01 / Zacks.com
Cyberonics Investors Okay Sorin Deal; LivaNova Coming Up
Sep 24 / Zacks.com
RTI Surgical: A Strong Buy on Q2 Results, Raised 2015 View
Sep 30 / Zacks.com